Kurisu K, Hishikawa Y, Taniguchi M, Kamikonya N, Miura T, Kanno H, Okamoto E
Department of Radiology, Hyogo College of Medicine, Japan.
Radiother Oncol. 1991 May;21(1):65-6. doi: 10.1016/0167-8140(91)90344-g.
Five patients with recurrent or residual bile duct carcinoma after surgery were treated with high-dose-rate intraluminal brachytherapy (HDRIBT) using a remote afterloader. External radiotherapy was also given in three cases. HDRIBT is considered to be an effective mode of radiotherapy for residual or recurrent bile duct tumors.
5例手术后复发或残留胆管癌患者采用遥控后装近距离放疗装置接受高剂量率腔内近距离放疗（HDRIBT）。3例患者还接受了体外放疗。HDRIBT被认为是治疗残留或复发性胆管肿瘤的一种有效放疗方式。
